Pemigatinib, an FGFR inhibitor, overcomes resistance to KRASG12C inhibitors in mesenchymal-like NSCLC tumors

Margaret Favata,Michael Weber, Angela Abdollahi, Valerie Dostalik Roman, Matt Farren, Aidan Gilmartin, Sunkyu Kim,Susan Wee,Jonathan Rios-Doria

CANCER RESEARCH(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要